Not applicableActive Not RecruitingNCT06362148What this trial is testingCirculating Tumor DNA in Peripheral T-cell LymphomasWho this might be right forPeripheral T-cell LymphomaNK/T-Cell Lymphoma University of Aarhus 50
Early research (Phase 1)Ended earlyNCT01644253What this trial is testingPhase 1b Safety and Efficacy Study of TRU-016Who this might be right forChronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma Aptevo Therapeutics 87
Early research (Phase 1)Study completedNCT00002946What this trial is testingPenclomedine in Treating Patients With Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT00637637What this trial is testingExternal-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesWho this might be right forCancer Oncology Institute of Southern Switzerland 60
Large-scale testing (Phase 3)Looking for participantsNCT07300514What this trial is testingGolidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell LymphomaWho this might be right forMaintenance Treatment of Peripheral T-cell Lymphoma Fudan University 136
Testing effectiveness (Phase 2)Looking for participantsNCT07555431What this trial is testingDolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 InfectionWho this might be right forHTLV-1 InfectionHTLV I Associated MyelopathiesHTLV I Associated T Cell Leukemia Lymphoma+1 more Carlos Brites 146
Testing effectiveness (Phase 2)Active Not RecruitingNCT04984837What this trial is testingStudy of Lacutamab in Peripheral T-cell LymphomaWho this might be right forPeripheral T Cell LymphomaRelapse/Recurrence The Lymphoma Academic Research Organisation 49
Testing effectiveness (Phase 2)Looking for participantsNCT05934513What this trial is testingGFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Who this might be right forRelapsed or Refractory Peripheral T-cell Lymphoma (PTCL) Genfleet Therapeutics (Shanghai) Inc. 95
Not applicableEnded earlyNCT00651716What this trial is testingT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT03586999What this trial is testingNivolumab With Standard of Care Chemotherapy for Peripheral T Cell LymphomasWho this might be right forPeripheral T Cell Lymphoma University of Colorado, Denver 18
Testing effectiveness (Phase 2)Ended earlyNCT03547700What this trial is testingStudy of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)Who this might be right forLymphoma, T-Cell, Peripheral University of Michigan Rogel Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00072514What this trial is testingGemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid MalignanciesWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more Fred Hutchinson Cancer Center 55
Large-scale testing (Phase 3)UnknownNCT03023358What this trial is testingCompared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma PatientsWho this might be right forPeripheral T Cell Lymphoma Nanfang Hospital, Southern Medical University 174
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07032532What this trial is testingAssessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)Who this might be right forPeripheral T Cell Lymphoma Sun Yat-sen University 35
Testing effectiveness (Phase 2)UnknownNCT05749549What this trial is testingPhase I/IIa Study of BR1733 in Subjects With Advanced CancersWho this might be right forAdvanced CancerFollicular LymphomaPeripheral T Cell Lymphoma+1 more Shanghai Blueray Biopharma Co., Ltd. 191
Testing effectiveness (Phase 2)Study completedNCT00901147What this trial is testingStudy of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell LymphomaWho this might be right forPeripheral T-cell Lymphoma (Not Otherwise Specified)Angioimmunoblastic T-cell LymphomaExtranodal NK/T-cell Lymphoma Nasal Type+4 more Singapore General Hospital 25
Early research (Phase 1)Ended earlyNCT06254495What this trial is testingA Safety Study of PF-08046044/SGN-35C in Adults With Advanced CancersWho this might be right forHodgkin DiseaseLymphoma, T-Cell, PeripheralLymphoma, Large B-Cell, Diffuse+1 more Seagen, a wholly owned subsidiary of Pfizer 58
Testing effectiveness (Phase 2)UnknownNCT03502629What this trial is testingClinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)Who this might be right forPeripheral T Cell Lymphoma Genor Biopharma Co., Ltd. 86
Very early researchLooking for participantsNCT07048353What this trial is testingCD30 CAR-T in the Treatment of CD30 Positive LymphomaWho this might be right forLymphomaB Cell LymphomaCD30+ Peripheral T-cell Lymphoma Shandong Qilu Cell Therapy Engineering Technology Co., Ltd 15
Testing effectiveness (Phase 2)Looking for participantsNCT06495723What this trial is testingPolyspecific Antibodies in Lymphoproliferative T-cell DisordersWho this might be right forPeripheral T Cells Lymphoma (PTCL) Xenothera SAS 54